Free Cash Flow

A new report details how interconnected apps, wearables, and AI are creating a 'Human Performance Economy' that extends far beyond the gym's walls.

After a swift restructuring, Modivcare emerges debt-light and privately owned, poised to aggressively invest in technology and transform supportive care.

Oncodesign Precision Medicine and Navigo Proteins end their radiotheranostics pact, shifting focus to internal programs amid high-stakes R&D challenges.

Beyond the grid, Xcel Energy invested over $14M and nearly 60,000 volunteer hours, strategically fueling local economies and its own green future.

The Danish firm scraps its 2025 revenue forecast, accepting a larger loss in a bold move to secure more lucrative future deals for its key drug candidates.

A successful demonstration of Revoltz's compact electric cargo vehicle to Israeli officials could signal a major shift in last-mile logistics.

Verizon's Q4 report will reveal if its FWA growth can offset mobile pressures and prove the new CEO's strategy is paying off for investors and customers.

Capital Clean Energy Carriers Corp. orders three advanced LNG carriers, positioning itself to capitalize on a projected surge in global gas demand.

Chegg repurchases convertible notes at a discount, a calculated move to strengthen its finances as it pivots to the competitive skilling market.

With $13.2 billion in assets and 3.41% of all ETH, Bitmine is on a quest for market dominance. A crucial shareholder vote will decide its future.

With promising new drugs for obesity and liver disease, clinical-stage MetaVia steps into the spotlight at a key industry conference, facing giants and high hopes.

With a promising schizophrenia drug stalled by FDA requirements and finances tight, Reviva Pharmaceuticals' upcoming presentation is more than just a talk.

Semiconductor metrology leader Nova adds seasoned investor Rami Hadar to its board, signaling a strategic push to accelerate growth and innovation.

EUDA Health's new Helixé 2.0 supplement boasts enhanced potency, nano-delivery tech, and Halal certification to capture the booming global wellness market.

Greenwich LifeSciences execs extend their stock lock-up to 6 years, signaling massive confidence in their breast cancer drug showing an 80% recurrence drop.

A $10.5M investment gives Enduring Wealth Capital near-majority control of Cango, accelerating its pivot to AI and raising questions about its future.

Mirum raises over a quarter-billion dollars to acquire Bluejay Therapeutics, targeting a high-potential liver disease drug and signaling major growth.

With a massive capital raise and rapid microreactor progress, NANO Nuclear is positioning itself to power the AI boom and lead a new nuclear renaissance.

WhiteFiber lands a 10-year, 40 MW anchor deal with AI provider Nscale, validating its high-density strategy and fueling North Carolina's tech boom.

Medical supply giant Medline closes 2025's largest IPO, raising billions to slash debt and fuel growth, cementing its dominance in the healthcare sector.